Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery

Obesity

Volumn 17, Issue 3, 2009, Pages 439-446

  Gletsu Miller, Nana ^a   Hansen, Jason M ^a   Jones, Dean P ^a   Go, Young Mi ^a   Torres, William E ^a   Ziegler, Thomas R ^a   Lin, Edward ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; DRUG DERIVATIVE; HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; TYROSINE;

ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD; BODY MASS; BODY WEIGHT; FEMALE; HUMAN; INTRAABDOMINAL FAT; LONGITUDINAL STUDY; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; SUBCUTANEOUS FAT; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; BARIATRIC SURGERY; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIPID PEROXIDES; LIPOPROTEINS, HDL; LONGITUDINAL STUDIES; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; REACTIVE OXYGEN SPECIES; SUBCUTANEOUS FAT; TYROSINE; WEIGHT LOSS;

EID: 60849129493     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.542     Document Type: Article

References (52)

1. James WPT The epidemiology of obesity: the size of the problem. J Intern Med 2008;263:336-352.
2. Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529.
3. Kadliska MB, Gladen BC, Baird DD et al. Biomarkers of Oxidative Stress Study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38:698-710.
4. Block G, Dietrich M, Norkus EP et al. Factors associated with oxidative stress In human populations. Am J Epidemiol 2002;156:274-285.
5. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes 2002;26:1159-1164.
6. Russell AP, Gastaldi G, Bobbioni-Harsch E et al. Lipid peroxidation In skeletal muscle of obese as compared to endurance-trained human: a case of good vs. bad lipids? FEBS Lett 2003;551:104-106.
7. Dandona P, Mohanty P, Ghanim H et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001;86:355-362.
8. Uzun H, Konukoglu D, Gelisgen R, Zengin K, Mustafa T. Plasma protein carbonyl and thiol stress before and after laparascopic gastric banding in morbidly obese patients. Obes Surg 2007;17:1367-1373.
9. Ozata M, Mergen M, Okenli C et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 2002;35:627-631.
10. Flagg EW, Coates RJ, Eley JW et al. Dietary glutatione intake in humans and the relationship between intake and plasma total glutathione level. Nutr Cancer 1994;21:33-46.
11. Hagen TM, Wierzbicka GT, Sillau AH, Bowman BB, Jones DP. Bioavailability of dietary glutathione: effect on plasma concentration. Am J Physiol 1990;259:G524-G529.
12. Lin E, Gletsu N, Fugate K et al. The effects of gastric division on systemic ghrelin concentrations in the morbidly obese. Gastroenterology 2003;124:754-761.
13. Brochu M, Starling RD, Tchernof A et al. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 2000;85:2378-2384.
14. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989;38:1512-1527.
15. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
16. Kvist H, Sjostrom L, Tylen U. Adipose tissue volume determination in women by computed tomography: technical considerations. Int J Obes 1986;10:53-67.
17. Kahn HS, Austin H, Williamson DF, Arensberg D. Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol 1996;49:1017-1024.
18. Cesarone MR, Carratelli M, Cornelli U et al. A simple test to monitor oxidative stress. Int Angiol 1999;18:127-130.
19. Vassale C, Boni C, DiCecco P, Ndreu R, Zucchelli GC. Automation and validation of a fast method for the assessment of in vivo oxidative stress levels. Clin Chem Lab Med 2006;44:1372-1375.
20. Abramson JL, Hooper WC, Jones DP et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 2005;178:115-121.
21. Newman RB, Bloom HL, Shukrullah I et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2008;53: 1652-1657.
22. Brennan M-L, Wu W, Fu X et al. A tale of two controversies. Defining both the role peroxidase in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of the peroxidase-generated reactive oxygen species. J Biol Chem 2002;277:17415-17427.
23. Grundy SM, Brewer HB Jr, Cleeman JL, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433-438.
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007;30:S42-S47.
25. Lin E, Phillips LS, Ziegler TR et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes 2007;56:735-742.
26. Gletsu N, Lin E, Khaitan L et al. Changes in C-reactive protein predict insulin sensitivity in severely obese individuals after weight loss surgery. J Gastrointest Surg 2005;9:1119-1128.
27. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesityinduced oxidant stress in humans. Int J Obes 2006;30:400-418.
28. Pihl E, Zilmer K, Kullisaar T et al. Atherogenic inflammatory and oxidative stress markers in relation to overweight values in male former athletes. Int J Obes 2006;30:141-146.
29. Furukawa S, Fujita T, Shimabujuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
30. Mutlu-Turkoglu U, Oztezcan S, Telci A et al. An increase in lipoprotein oxidation and endogenous and lipid peroxides in serum of obese women. Clin Exp Med 2003;2:171-174.
31. Kisakol G, Guney E, Bayrakatar F et al. Effect of surgical weight loss of free radical and antioxidant balance: a preliminary report. Obes Surg 2002;12:800-801.
32. Chen G, Heilbrun LK, Venkatramanamoorthy R et al. Effects of low-fat and/ or high-fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2alpha in the Nutrition and Breast Health Study. Nutr Cancer 2004;50:155-160.
33. Vincent HK, Bourguignon C, Vincent KR. Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults. Obesity 2006;14:1921-1930.
34. Rector RS, Warner SO, Liu Y et al. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab 2007;293:E500-E506.
35. Yesilbursa D, Serdar Z, Serdar A et al. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels. Int J Obes 2005;29:142-145.
36. Galinier A, Carriere A, Fernandez Y et al. Site specific changes of redox metabolism in adipose tissue of obese Zucker rats. FEBS Lett 2006;580: 6391-6398.
37. Yu R, Kim C-S, Kwon B-S, Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity 2006;14: 1353-1362.
38. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
39. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830.
40. Wu H, Ghosh S, Perrard XD et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007;115:1029-1038.
41. Cancello R, Henegar C, Viguerie N et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277-2286.
42. Clement K, Viguerie N, Poitou C et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004;18:1657-1669.
43. Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circulation J 2006;70:1437-1442.
44. Pou KM, Massaro JM, Hoffman U et al. Visceral and subcutaneous tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress. Circulation 2007;116:1234-1241.
45. Keaney JFJ, Larson MG, Vasan RS et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003;23:434-439.
46. Ashfaq S, Abramson JL, Jones DP et al. Relationship between plasma levels of oxidized and reduced thiols and early artherosclerosis in healthy adults. J Am Coll Cardiol 2006;47:1005-1011.
47. Arca M, Natoli S, Micheletta F et al. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med 2007;42:698-705.
48. Sinaiko AR, Steinberger J, Moran A et al. Relation of and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005;111:1985-1991.
49. Konukoglu D, Serin O, Ercan M, Turhan MS. Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper. Clin Biochem 2003;36: 405-408.
50. Watson AD, Berliner JA, Hama SY et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96: 2882-2891.
51. Lakshman MR, Gottipati CS, Narasimhan SJ et al. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus. Metab Clin Exp 2006;55:1201-1206.
52. Grundy SM, Brewer HBJ, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the NHLBI/AHA Conference on Scientific Issues Related to Definition. Circulation 2004;109:433-438.